Mannitol Viaflo Baxter

Mannitol, the active ingredient in Mannitol Viaflo Baxter, is an osmotic diuretic presented as an intravenous solution for intravenous use. It reduces intracranial pressure, treats cerebral edema, lowers intraocular pressure, and promotes diuresis in acute renal failure in patients with critical conditions and in emergency settings.

GNH USA supplies Mannitol Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance and timely delivery.

Mannitol is used in clinical settings to manage conditions involving fluid overload or elevated pressure within the central nervous system and eye. - Reduction of intracranial pressure: lowers pressure within the skull by osmotic dehydration of brain tissue. - Treatment of cerebral edema: decreases brain swelling through removal of excess fluid from cerebral tissue. - Reduction of intraocular pressure: lowers pressure inside the eye by drawing fluid out of ocular tissues. - Promotion of diuresis in acute renal failure: enhances urine output to assist kidney function when it is compromised. - Facilitation of renal excretion of toxins: increases urinary elimination of certain nephrotoxic substances.

Mannitol may be associated with a range of adverse reactions, varying from mild to severe. Common Side Effects: - Headache: mild to moderate pain during infusion. - Nausea/vomiting: gastrointestinal upset related to osmotic shifts. - Electrolyte imbalance: alterations in serum sodium or potassium. Serious or Rare Side Effects: - Acute renal failure: worsening kidney function in at‑risk patients. - Pulmonary edema: fluid overload leading to lung congestion. - Anaphylaxis: severe allergic reaction requiring immediate intervention.

When using Mannitol, careful clinical monitoring is essential. - Renal function: assess baseline kidney status before initiating therapy. - Electrolyte monitoring: regularly check serum sodium and potassium during treatment. - Cardiovascular status: observe blood pressure and heart rate for hypotension or tachycardia. - Fluid balance: avoid excessive volume administration that may cause overload. - Pregnancy and lactation: use only if clearly indicated, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with several drug classes. Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause severe electrolyte depletion. - Insulin: osmotic shifts can potentiate hypoglycemia. - ACE inhibitors/ARBs: combined use may increase risk of renal impairment. Moderate Interactions (Monitor Closely): - Nephrotoxic antibiotics (e.g., aminoglycosides): monitor renal function closely. - Hypertonic saline: may lead to excessive osmolar load and fluid imbalance.